UBS OCONNOR LLC - INTERCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$778,000,000
-20.4%
1,000,0000.0%0.01%
-31.2%
Q2 2017$978,000,000
+4.4%
1,000,0000.0%0.02%0.0%
Q1 2017$937,000,000
+4.6%
1,000,0000.0%0.02%
-5.9%
Q4 2016$896,000,0001,000,0000.02%
Other shareholders

There were no reported owners of INTERCEPT PHARMACEUTICALS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders